Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 35, 2023 - Issue 4
219
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Barriers to accessing pre-exposure prophylaxis among women experiencing intimate partner violence in the United States: a systematic literature review

ORCID Icon &
Pages 509-523 | Received 09 Mar 2022, Accepted 01 Sep 2022, Published online: 14 Sep 2022

References

  • Auerbach, J. D., Kinsky, S., Brown, G., & Charles, V. (2015). Knowledge, attitudes, and likelihood of Pre-exposure prophylaxis (PrEP) Use Among US women at risk of acquiring HIV. AIDS Patient Care and STDs, 29(2), 102–110. https://doi.org/10.1089/apc.2014.0142
  • Bradley, E. L. P., Forsberg, K., Betts, J. E., DeLuca, J. B., Kamitani, E., Porter, S. E., Sipe, T. A., & Hoover, K. W. (2019). Factors affecting Pre-exposure prophylaxis implementation for women in the United States: A systematic review. Journal of Women's Health, 28(9), 1272–1285. https://doi.org/10.1089/jwh.2018.7353
  • Bradley, E. L. P., & Hoover, K. W. (2019). Improving HIV preexposure prophylaxis implementation for women: Summary of Key findings from a discussion series with women’s HIV prevention experts. Women's Health Issues, 29(1), 3–7. https://doi.org/10.1016/j.whi.2018.08.004
  • Braksmajer, A., Leblanc, N. M., El-Bassel, N., Urban, M. A., & McMahon, J. M. (2019). Feasibility and acceptability of pre-exposure prophylaxis use among women in violent relationships. AIDS Care, 31(4), 475–480. https://doi.org/10.1080/09540121.2018.1503634
  • Breiding M.J., Basile K.C., Smith S.G., Black M.C., & Mahendra R.R. (2015). Intimate Partner Violence Surveillance: Uniform Definitions and Recommended Data Elements, Version 2.0. Atlanta, GA: National Center for Injury Prevention and Control, Centers for Disease Control and Prevention
  • Calabrese, S. K., Dovidio, J. F., Tekeste, M., Taggart, T., Galvao, R. W., Safon, C. B., Willie, T. C., Caldwell, A., Kaplan, C., & Kershaw, T. S. (2018). HIV Pre-Exposure prophylaxis stigma as a multidimensional barrier to uptake Among women Who attend planned parenthood. JAIDS Journal of Acquired Immune Deficiency Syndromes, 79(1), 46–53. https://doi.org/10.1097/QAI.0000000000001762
  • Calabrese, S. K., & Underhill, K. (2015). How stigma surrounding the Use of HIV preexposure prophylaxis undermines prevention and pleasure: A call to destigmatize “truvada whores”. American Journal of Public Health, 105(10), 1960–1964. https://doi.org/10.2105/AJPH.2015.302816
  • Calabrese, S. K., Willie, T. C., Galvao, R. W., Tekeste, M., Dovidio, J. F., Safon, C. B., Blackstock, O., Taggart, T., Kaplan, C., Caldwell, A., & Kershaw, T. S. (2019). Current US guidelines for prescribing HIV Pre-exposure prophylaxis (PrEP) disqualify many women Who Are at risk and motivated to Use PrEP. JAIDS Journal of Acquired Immune Deficiency Syndromes, 81(4), 395–405. https://doi.org/10.1097/QAI.0000000000002042
  • Campbell, J. C., Baty, M. L., Ghandour, R. M., Stockman, J. K., Francisco, L., & Wagman, J. (2008). The intersection of intimate partner violence against women and HIV/AIDS: A review. International Journal of Injury Control and Safety Promotion, 15(4), 221–231. https://doi.org/10.1080/17457300802423224
  • Caplon, A., Alexander, K. A., Kershaw, T., & Willie, T. C. (2021). Assessing provider-, clinic-, and structural-level barriers and recommendations to Pre-exposure prophylaxis (PrEP) uptake: A qualitative investigation Among women experiencing intimate partner violence, intimate partner violence service providers, and healthcare providers. AIDS and Behavior, 25(10), 3425–3436. https://doi.org/10.1007/s10461-021-03297-7
  • Centers for Disease Control and Prevention. (2021). HIV Infection, Risk, Prevention, and Testing Behaviors Among Heterosexually Active Adults at Increased Risk for HIV Infection—National HIV Behavioral Surveillance, 23 U.S. Cities, 2019. https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
  • Chan, E., Catabay, C. J., Campbell, J. C., Rudolph, A. E., Stockman, J. K., & Tsuyuki, K. (2021). Feminine gender norms and syndemic harmful drinking, sexual violence, and sexually transmitted infections among black women at risk for HIV. Drug and Alcohol Dependence, 221, 108566. https://doi.org/10.1016/j.drugalcdep.2021.108566
  • Dunkle, K. L., & Decker, M. R. (2013). Gender-Based violence and HIV: Reviewing the evidence for links and causal pathways in the general population and high-risk groups. American Journal of Reproductive Immunology, 69(s1), 20–26. https://doi.org/10.1111/aji.12039
  • FDA News Release. (2021). FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention. https://www.hiv.gov/blog/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention?utm_source=email&utm_medium=email&utm_campaign=daily20211221&utm_content=federalresponse
  • Flash, C. A., Stone, V. E., Mitty, J. A., Mimiaga, M. J., Hall, K. T., Krakower, D., & Mayer, K. H. (2014). Perspectives on HIV prevention among urban black women: A potential role for HIV pre-exposure prophylaxis. AIDS Patient Care and STDs, 28(12), 635–642. https://doi.org/10.1089/apc.2014.0003
  • Garfinkel, D. B., Alexander, K. A., McDonald-Mosley, R., Willie, T. C., & Decker, M. R. (2017). Predictors of HIV-related risk perception and PrEP acceptability among young adult female family planning patients. AIDS Care, 29(6), 751–758. https://doi.org/10.1080/09540121.2016.1234679
  • Goparaju, L., Praschan, N. C., Warren-Jeanpiere, L., Experton, L. S., Young, M. A., & Kassaye, S. (2017). Stigma, partners, providers and costs: Potential barriers to PrEP uptake among US women. Journal of AIDS & Clinical Research, 08((09|9)), 9. https://doi.org/10.4172/2155-6113.1000730
  • Hong, Q. N. (2020). Questions on the MMAT version 2018. http://mixedmethodsappraisaltoolpublic.pbworks.com/w/page/71030694/FAQ
  • Hong, Q. N., Fàbregues, S., Bartlett, G., Boardman, F., Cargo, M., Dagenais, P., Gagnon, M.-P., Griffiths, F., Nicolau, B., & O’Cathain, A. (2018a). The mixed methods appraisal tool (MMAT) version 2018 for information professionals and researchers. Education for Information, 34(4), 285–291. https://doi.org/10.3233/EFI-180221
  • Hong, Q. N., Pluye, P., Fàbregues, S., Bartlett, G., Boardman, F., Cargo, M., Dagenais, P., Gagnon, M.-P., Griffiths, F., & Nicolau, B. (2018b). Mixed methods appraisal tool (MMAT), version 2018. Registration of Copyright (#1148552), Canadian Intellectual Property Office.
  • Institute of Medicine. (2011). Clinical practice guidelines We Can trust (R. Graham, M. Mancher, D. M. Wolman, S. Greenfield, & E. Steinberg (eds.)). The National Academies Press. https://doi.org/10.17226/13058
  • Li, Y., Marshall, C. M., Rees, H. C., Nunez, A., Ezeanolue, E. E., & Ehiri, J. E. (2014). Intimate partner violence and HIV infection among women: A systematic review and meta-analysis. Journal of the International AIDS Society, 17(1), 18845. https://doi.org/10.7448/IAS.17.1.18845
  • Nydegger, L. A., Dickson-Gomez, J., & Ko, T. K. (2020). Structural and syndemic barriers to PrEP adoption among black women at high risk for HIV: A qualitative exploration. Culture, Health & Sexuality, 659–673. https://doi.org/10.1080/13691058.2020.1720297
  • Oldenburg, C. E., Perez-Brumer, A. G., & Reisner, S. L. (2014). Poverty matters: contextualizing the syndemic condition of psychological factors and newly diagnosed HIV infection in the United States, Aids (london, England)), 28(18), 2763–2769. https://doi.org/10.1097/QAD.0000000000000491
  • O’Malley, T. L., Egan, J. E., Hawk, M. E., Krier, S. E., & Burke, J. G. (2020a). Intersection of intimate partner violence and pre-exposure prophylaxis: Exploring HIV worry and PrEP acceptability among women. Violence Against Women, 27, https://doi.org/10.1177/1077801220969874
  • O’Malley, T. L., Egan, J. E., Hawk, M. E., Krier, S. E., & Burke, J. G. (2021). Intimate partner violence, HIV Pre-exposure prophylaxis (PrEP) acceptability, and attitudes about Use: Perspectives of women seeking care at a family planning clinic. AIDS and Behavior, 25(2), 427–437. https://doi.org/10.1007/s10461-020-03003-z
  • O’Malley, T. L., Hawk, M. E., Egan, J. E., Krier, S. E., & Burke, J. G. (2020b). Intimate partner violence and Pre-exposure prophylaxis (PrEP): A rapid review of current evidence for women’s HIV prevention. AIDS and Behavior, 24(5), 1342–1357. https://doi.org/10.1007/s10461-019-02743-x
  • Opoku-Anane, J., Diouf, K., & Nour, N. M. (2012). New success With microbicides and Pre-exposure prophylaxis for human immunodeficiency virus (HIV): Is female-controlled prevention the answer to the HIV epidemic? Reviews in Obstetrics & Gynecology, 5(1), 50–55.
  • Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
  • PCORI. (2019). PICORI Methodology Standards. https://www.pcori.org/research-results/about-our-research/research-methodology/pcori-methodology-standards#Systematic Reviews
  • Peitzmeier, S. M., Tomko, C., Wingo, E., Sawyer, A., Sherman, S. G., Glass, N., Beyrer, C., & Decker, M. R. (2017). Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city. AIDS Care, 29(11), 1453–1457. https://doi.org/10.1080/09540121.2017.1300628
  • Qin, Y., Price, C., Rutledge, R., Puglisi, L., Madden, L. M., & Meyer, J. P. (2020). Women’s decision-making about PrEP for HIV prevention in drug treatment contexts. Journal of the International Association of Providers of AIDS Care (JIAPAC), 19, 232595821990009. https://doi.org/10.1177/2325958219900091
  • Raifman, J., & Sherman, S. G. (2018). US guidelines that empower women to prevent HIV with pre-exposure prophylaxis. Sexually Transmitted Diseases, 45(6), e38. https://doi.org/10.1097/OLQ.0000000000000811
  • Rubtsova, A., Wingood, G. M., Dunkle, K., Camp, C., & DiClemente, R. J. (2014). Young Adult Women and Correlates of Potential Adoption of Pre-Exposure Prophylaxis (PrEP): Results of a National Survey. Current HIV Research, 11(7, SI), 543–548. https://doi.org/10.2174/1570162X12666140129104952
  • Siegler, A. J., Mouhanna, F., Giler, R. M., Weiss, K., Pembleton, E., Guest, J., Jones, J., Castel, A., Yeung, H., Kramer, M., McCallister, S., & Sullivan, P. S. (2018). The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis–to-need ratio in the fourth quarter of 2017, United States. Annals of Epidemiology, 28(12), 841–849. https://doi.org/10.1016/j.annepidem.2018.06.005
  • Singer, M. C. (1994). Aids and the health crisis of the U.S. Urban poor; the perspective of critical medical anthropology. Social Science & Medicine, 39(7), 931–948. https://doi.org/10.1016/0277-9536(94)90205-4
  • Singer, M. C., Erickson, P. I., Badiane, L., Diaz, R., Ortiz, D., Abraham, T., & Nicolaysen, A. M. (2006). Syndemics, sex and the city: Understanding sexually transmitted diseases in social and cultural context. Social Science & Medicine, 63(8), 2010–2021. https://doi.org/10.1016/j.socscimed.2006.05.012
  • Tomko, C., Allen, S. T., Glick, J., Sherman, S. G., Park, J. N., Galai, N., Decker, M. R., & Footer, K. H. A. (2019). Awareness and interest in HIV Pre-exposure prophylaxis Among street-based female Sex workers: Results from a US context. AIDS Patient Care and STDs, 33(2), 49–57. https://doi.org/10.1089/apc.2018.0182
  • Villalba, K., Jean-Gilles, M., Rosenberg, R., Cook, R. L., Ichite, A., Martin, P., & Devieux, J. G. (2021). Understanding the impact of intimate partner violence type and timing on Pre-exposure prophylaxis knowledge, acceptability, sexual behavior, and gender roles Among women of color. Journal of Interpersonal Violence, https://doi.org/10.1177/08862605211001468
  • Wheelock, A., Eisingerich, A. B., Gomez, G. B., Gray, E., Dybul, M. R., & Piot, P. (2012). Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study. BMJ Open, 2(4), e001234. https://doi.org/10.1136/bmjopen-2012-001234
  • Willie, T. C., Keene, D. E., Kershaw, T. S., & Stockman, J. K. (2020a). “You never know what could happen”: women’s perspectives of Pre-exposure prophylaxis in the context of recent intimate partner violence. Women's Health Issues, 30(1), 41–48. https://doi.org/10.1016/j.whi.2019.08.001
  • Willie, T. C., Keene, D. E., Stockman, J. K., Alexander, K. A., Calabrese, S. K., & Kershaw, T. S. (2020b). Intimate partner violence influences women’s engagement in the early stages of the HIV Pre-exposure prophylaxis (PrEP) care continuum: Using doubly robust estimation. AIDS and Behavior, 24(2), 560–567. https://doi.org/10.1007/s10461-019-02469-w
  • Willie, T. C., Kershaw, T., Campbell, J., & Alexander, K. (2017). Intimate partner violence and PrEP acceptability Among Low-income, young black women: Exploring the mediating role of reproductive coercion. AIDS and Behavior, 21(8), 2261–2269. https://doi.org/10.1007/s10461-017-1767-9
  • Willie, T. C., Stockman, J. K., Keene, D. E., Calabrese, S. K., Alexander, K. A., & Kershaw, T. S. (2019). Social networks and Its impact on women’s awareness, interest, and uptake of HIV Pre-exposure prophylaxis (PrEP): implications for women experiencing intimate partner violence. JAIDS Journal of Acquired Immune Deficiency Syndromes, 80(4), 386–393. https://doi.org/10.1097/QAI.0000000000001935
  • Willie, T. C., Stockman, J. K., Overstreet, N. M., & Kershaw, T. S. (2018). Examining the impact of intimate partner violence type and timing on Pre-exposure prophylaxis awareness, interest, and coercion. AIDS and Behavior, 22(4), 1190–1200. https://doi.org/10.1007/s10461-017-1901-8
  • Wingood, G. M., Dunkle, K., Camp, C., Patel, S., Painter, J. E., Rubtsova, A., & DiClemente, R. J. (2013). Racial differences and correlates of potential adoption of preexposure prophylaxis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 63(1), S95–S101. https://doi.org/10.1097/QAI.0b013e3182920126

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.